Yutaka Osuga

No ORCID on file · 275 papers in corpus · active 1995-2026

Study types

  • article 199
  • other 29
  • review 13
  • preprint 10
  • book-chapter 7

Condition tags

  • endometriosis 201
  • adenomyosis 54
  • endometrioma 38
  • dysmenorrhea 28
  • infertility 24
  • chronic_pelvic_pain 11
  • dyspareunia 5
  • bowel_endometriosis 4
  • bladder_endometriosis 3
  • mesh:D004716 3
rct
Fertility and sterility ·doi:10.1016/j.fertnstert.2024.11.003

OBJECTIVE: To evaluate the efficacy and safety of the estetrol (E4) (15 mg)/drospirenone (DRSP) (3 mg) combination in a cyclic regimen in Japanese women with primary and secondary dysmenorrhea. DESIGN: A 16-week, multicenter, randomized, d…

2026
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.70182

The introduction of oral GnRH antagonists has created the possibility to replace progestins in combined oral contraceptives as the suppressor of ovarian function. A concept for this new approach to oral hormonal contraception is the combina…

other 2026
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-025-02045-9

The association between adenomyosis and uterine torsion, a rare, serious obstetric condition, remains unclear and has not been systematically investigated. This study aimed to elucidate the incidence, risk factors, and clinical characterist…

preprint 2026
·doi:10.21203/rs.3.rs-8631039/v1

Abstract Background: The implantation (retrograde menstruation) theory hypothesizes that endometriosis arises when refluxed endometrial cells implant at ectopic sites; however, a fallopian tube epithelial origin has also been proposed. …

other 2026
Reproductive medicine and biology ·doi:10.1002/rmb2.70021

PURPOSE: To clarify the efficacy and safety of the estetrol 15 mg/drospirenone 3 mg combination among Japanese women with adenomyosis by post hoc analyses of a previous randomized clinical study. METHODS: Post hoc analyses were performed u…

2026
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics ·doi:10.1002/ijgo.70835

ObjectiveCombined oral contraceptives (COCs) for dysmenorrhea management have been covered by the Japanese universal health insurance system since 2008. Several public awareness events regarding COC prescriptions for dysmenorrhea were imple…

2026
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics ·doi:10.1002/ijgo.70752

ObjectiveTo assess the background, psychosocial, and menstrual factors associated with premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) in a community-based cohort.MethodsA prospective cohort study was conducted using …

article 2026
·doi:10.1016/j.jri.2026.104933
2025
Advances in therapy ·doi:10.1007/s12325-025-03123-9

IntroductionTreatment interruptions due to adverse drug reactions (ADRs) are common in iron deficiency anemia (IDA). We evaluated medication completion rates and quality of life (QoL) changes in patients with IDA after starting ferric citra…

article 2025
·doi:10.1142/s2661318225500070

Background: Effective management of endometriosis necessitates a comprehensive, multidisciplinary approach. Networks or centres of expertise play a pivotal role in enhancing clinical care, fostering collaboration, and promoting innovative r…

article 2025
BMC pregnancy and childbirth ·doi:10.1186/s12884-025-08454-7

BACKGROUND: With the increasing incidence of autism spectrum disorder (ASD), various risk factors for ASD have been identified. Among them, maternal immune activation (MIA), which can be triggered by inflammation via elevated proinflammator…

case-report 2025
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.70140

Patients with endometriosis are at a high risk of developing pelvic inflammatory disease. This case series presents three cases of colo-ovarian fistulas associated with endometriosis, highlighting the potential for conservative management i…

other 2025
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2024.07.021
article 2025
Fertility and Sterility ·doi:10.1016/j.fertnstert.2025.07.168
article 2025
Reproductive medicine and biology ·doi:10.1002/rmb2.12654

PURPOSE: This study evaluated whether embryo cryopreservation before surgery (ECBS) improves clinical outcomes in in vitro fertilization (IVF) patients with endometrioma. METHODS: This retrospective study included patients aged 28-42 years…

other 2025
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-024-01758-7

Adenomyomectomy, a therapeutic option for women with adenomyosis who wish to preserve their fertility, has been reported to pose a risk of developing placenta accreta spectrum (PAS) and uterine rupture in future pregnancies. However, the sp…

other 2025
Trials ·doi:10.1186/s13063-025-08750-9

BACKGROUND: Endometriosis presents as endometrial tissue growths outside the uterine cavity with its major symptoms including dysmenorrhea and infertility. Progestin preparations, such as dienogest, are the first-line therapy for endometrio…

article 2025
·doi:10.1093/humrep/deaf097.083

Abstract Study question What is the involvement of DNA double-strand breaks (DDSBs) signaling pathway in primordial follicle depletion in endometriosis and the role of melatonin in this pathway? Summary answer Endometriosis increases percen…

article 2025
BMC women's health ·doi:10.1186/s12905-025-03817-w

Adenomyosis often causes dysmenorrhea in women of reproductive age. Progestins such as levonorgestrel intrauterine system (LNG-IUS) are often used for treatment, but some patients experience progesterone resistance, showing poor treatment r…

article 2025
F&S science ·doi:10.1016/j.xfss.2025.06.002

OBJECTIVE: To compare the transcriptomes induced by estrogens used in combined oral contraceptives (COCs): estetrol (E4), ethinylestradiol (EE), and estradiol (E2) in human primary endometriotic stromal cells. DESIGN: Endometriotic stromal…

preprint 2025
·doi:10.22541/au.174840847.70922257/v1

Objective: To elucidate the incidence, risk factors, and clinical characteristics of uterine torsion in pregnancies complicated by adenomyosis, which remains unstudied to date. Design: Retrospective cohort study. Setting: University Hospita…

article 2024
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2024.02.004

This group was formed out of the conviction that endometriosis research has not progressed at a pace in proportion to disease severity and the negative impact on women's quality of life. Furthermore, advancement in our understanding of this…

case-report 2024
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.16185

Uterine adenomyosis is a common disease in women of reproductive age that causes dysmenorrhea, abnormal uterine bleeding, infertility, and obstetric complications. Rarely, adenomyosis can lead to abscess formation, which is refractory to an…

letter 2024
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2024.04.008
article 2024
Reproductive health ·doi:10.1186/s12978-024-01739-8

BACKGROUND: Endometriosis-related pain encompassing dysmenorrhea, dyspareunia, and chronic pelvic pain, reduces the quality of life in premenopausal women. Although treatment options for endometriosis alleviate this pain, approximately one-…